Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-002872
Filing Date
2025-01-07
Accepted
2025-01-07 16:30:06
Documents
1
Period of Report
2025-01-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3852
  Complete submission text file 0000950170-25-002872.txt   5295
Mailing Address INDEVUS PHARMACEUTICALS, INC. 99 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Tucker John H (Reporting) CIK: 0001303480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38293 | Film No.: 25515210

Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)